2seventy bio, Inc.
TSVT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $154 | $210 | $334 | $604 |
| - Cash | $71 | $75 | $71 | $130 |
| + Debt | $244 | $257 | $270 | $282 |
| Enterprise Value | $326 | $392 | $533 | $756 |
| Revenue | $38 | $100 | $91 | $55 |
| % Growth | -62.3% | 9.7% | 67.8% | – |
| Gross Profit | $15 | $83 | $65 | $42 |
| % Margin | 40.4% | 83.1% | 71.3% | 76.9% |
| EBITDA | -$98 | -$206 | -$251 | -$297 |
| % Margin | -260% | -205.6% | -274.7% | -545% |
| Net Income | -$57 | -$218 | -$254 | -$276 |
| % Margin | -151.2% | -216.7% | -277.8% | -506.6% |
| EPS Diluted | -1.1 | -4.42 | -7.13 | -11.71 |
| % Growth | 75.1% | 38% | 39.1% | – |
| Operating Cash Flow | -$85 | -$167 | -$237 | -$207 |
| Capital Expenditures | -$1 | -$14 | -$23 | -$20 |
| Free Cash Flow | -$86 | -$181 | -$260 | -$227 |